SCHEMBL29259157

SCHEMBL29259157

CC(CC(=O)O)OCCOCc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
TSHR P16473 1/20 0.42
ALDH1A1 P00352 1/20 0.42
NPC1 O15118 1/20 0.42
FOLH1 Q04609 1/20 0.41
CTSB P07858 1/20 0.41
MMP2 P08253 1/20 0.41
MMP12 P39900 1/20 0.41
FFAR1 O14842 2/20 0.40
CPA1 P15085 2/20 0.40
MAOB P27338 1/20 0.40
CPB1 P15086 1/20 0.40
CPA3 P15088 1/20 0.40
CPB2 Q96IY4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2317601 0.85 KMT2A (0.49) SMN1; SMN2TSHRALDH1A1FFAR1CPA1
SCHEMBL7929513 0.85 KMT2A (0.49) SMN1; SMN2TSHRALDH1A1FFAR1CPA1
SCHEMBL6824207 0.85 KMT2A (0.49) SMN1; SMN2TSHRALDH1A1FFAR1CPA1
SCHEMBL3510081 0.82 TSHR (0.47) HTTSMN1; SMN2TSHRALDH1A1CTSB
SCHEMBL19434515 0.81 HTT (0.44) HTTSMN1; SMN2TSHRALDH1A1NPC1
SCHEMBL29101924 0.81 HTT (0.47) HTTSMN1; SMN2TSHRALDH1A1FOLH1
SCHEMBL27129558 0.81 TSHR (0.45) HTTSMN1; SMN2TSHRALDH1A1CTSB
SCHEMBL27032236 0.81 TSHR (0.45) HTTSMN1; SMN2TSHRALDH1A1CTSB
SCHEMBL27032017 0.81 TSHR (0.45) HTTSMN1; SMN2TSHRALDH1A1CTSB
SCHEMBL3512342 0.81 SMN1; SMN2 (0.48) HTTSMN1; SMN2TSHRALDH1A1CTSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117916225-A N-heterocyclyl substituted 2-cyano-3- (naphthalen-2-yl) acrylamide derivatives as fluorophores for detection of amyloid and amyloid-like proteins for diagnosis of neurodegenerative disorders 阿米达斯公司 2024-04-19 CN disclosed